The "Vaccine 2.0" Breakthrough: Is 2026 the Year of the "Universal Sugar Vaccine"?
A major shift in the 2026 global industry is the implementation of "Glyco-Conjugate Vaccine Design." This year, to combat the global rise in antibiotic-resistant bacteria, the Glycomics Market has perfected the art of "Targeting the Sugar Shell" of pathogens. This level of "Surface-Level Identification" is the new gold standard, allowing for vaccines that train the immune system to recognize...
0 Comentários 0 Compartilhamentos 6 Visualizações 0 Anterior
Lifesone https://lifesone.com